Dr. Reddy's Laboratories Ltd

Dr. Reddy’s Laboratories is a major Indian pharmaceutical company with a portfolio of 400+ generic drugs, APIs, and biosimilars. It has delivered strong returns, surging 37% over the past year and nearly 120% over five years, driven by global generics and innovation. With 46% of revenue from North America, 18% emerging markets, and 16% from India, its global presence is robust. Strengths include diverse products and strong financials (12% CAGR in revenue, 39% CAGR net profit, last five years), though price erosion and regulatory risks persist.